Last reviewed · How we verify
Pregabalin 300mg
Pregabalin 300mg is a Small molecule drug developed by University of Missouri-Columbia. It is currently FDA-approved. Also known as: Lyrica, Gabapentinoid, Preemptive analgesia, GLA5PR GLARS-NF1 tablet 300mg.
At a glance
| Generic name | Pregabalin 300mg |
|---|---|
| Also known as | Lyrica, Gabapentinoid, Preemptive analgesia, GLA5PR GLARS-NF1 tablet 300mg, P300 |
| Sponsor | University of Missouri-Columbia |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pregabalin vs. Gabapentin on Reducing Opioid Usage (PHASE4)
- SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy. (PHASE2)
- Perioperative Pregabalin in Ureteroscopy (PHASE2, PHASE3)
- Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults (EARLY_PHASE1)
- Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia (NA)
- Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery (PHASE4)
- Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users (PHASE4)
- Management of Pain Associated With Failed Back Surgery Syndrome (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pregabalin 300mg CI brief — competitive landscape report
- Pregabalin 300mg updates RSS · CI watch RSS
- University of Missouri-Columbia portfolio CI
Frequently asked questions about Pregabalin 300mg
What is Pregabalin 300mg?
Pregabalin 300mg is a Small molecule drug developed by University of Missouri-Columbia.
Who makes Pregabalin 300mg?
Pregabalin 300mg is developed and marketed by University of Missouri-Columbia (see full University of Missouri-Columbia pipeline at /company/university-of-missouri-columbia).
Is Pregabalin 300mg also known as anything else?
Pregabalin 300mg is also known as Lyrica, Gabapentinoid, Preemptive analgesia, GLA5PR GLARS-NF1 tablet 300mg, P300.
What development phase is Pregabalin 300mg in?
Pregabalin 300mg is FDA-approved (marketed).
Related
- Manufacturer: University of Missouri-Columbia — full pipeline
- Also known as: Lyrica, Gabapentinoid, Preemptive analgesia, GLA5PR GLARS-NF1 tablet 300mg, P300
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing